Other Drugs
| No. | Product Name | Specification | US DMF | EU DMF | CEP | JP DMF | CDE Status |
|---|---|---|---|---|---|---|---|
| 1 | Acarbose 阿卡波糖 |
USP, EP, CP, JP, In house | ● | ● | ● | A | |
| USP, EP, CP, JP, In house | The document has been approved | The document has been approved | The document has been approved | APIs that have been approved for use in finished dosage in China | |||
| 2 | Ademetionine 1, 4-butanedisulfonate 1, 4-丁二磺酸腺苷蛋氨酸 |
YBH | ● | A | |||
| YBH | APIs that have been approved for use in finished dosage in China | ||||||
| 3 | Apixaban 阿哌沙班 |
In house | ● | A | |||
| In house | The document has been approved | APIs that have been approved for use in finished dosage in China | |||||
| 4 | Apremilast 阿普司特 |
In house | |||||
| In house | |||||||
| 5 | Aripiprazole 阿立哌唑 |
USP, EP, In house | ● | A | |||
| USP, EP, In house | The document has been approved | APIs that have been approved for use in finished dosage in China | |||||
| 6 | Dabigatran Etexilate Mesylate 甲磺酸达比加群酯 |
In house | ● | ||||
| In house | The document has been approved | ||||||
| 7 | Eltrombopag Olamine 艾曲波帕乙醇胺 |
In house | |||||
| In house | |||||||
| 8 | Glutathione 谷胱甘肽 |
YBH | A | ||||
| YBH | APIs that have been approved for use in finished dosage in China | ||||||
| 9 | Loxapine Succinate 丁二酸洛沙平 |
In house | A | ||||
| In house | APIs that have been approved for use in finished dosage in China | ||||||
| 10 | Lurasidone HCl 盐酸鲁拉西酮 |
In house | ● | A | |||
| In house | The document has been approved | APIs that have been approved for use in finished dosage in China | |||||
| 11 | Mycophenolate Mofetil 吗替麦考酚酯 |
USP, EP, CP | ● | ● | A | ||
| USP, EP, CP | The document has been approved | The document has been approved | APIs that have been approved for use in finished dosage in China | ||||
| 12 | Olanzapine 奥氮平 |
USP | ● | ||||
| USP | The document has been approved | ||||||
| 13 | Orlistat 奥利司他 |
USP, In house | ● | A | |||
| USP, In house | APIs that have been approved for use in finished dosage in China | ||||||
| 14 | Oseltamivir Phosphate 磷酸奥司他韦 |
CP、USP、EP、In house | |||||
| CP、USP、EP、In house | |||||||
| 15 | Parecoxib Sodium 帕瑞昔布钠 |
In house | A | ||||
| In house | APIs that have been approved for use in finished dosage in China | ||||||
| 16 | Sirolimus 西罗莫司 |
In house | ● | ● | A | ||
| In house | The document has been approved | APIs that have been approved for use in finished dosage in China | |||||
| 17 | Solifenacin Succinate 琥珀酸索利那新 |
In house | A | ||||
| In house | APIs that have been approved for use in finished dosage in China | ||||||
| 18 | Tofacitinib Citrate 枸橼酸托法替布 |
In house | A | ||||
| In house | APIs that have been approved for use in finished dosage in China | ||||||
| 19 | Tacrolimus 他克莫司 |
USP, EP, IP | ● | ● | A | ||
| USP, EP, IP | The document has been approved | The document has been approved | APIs that have been approved for use in finished dosage in China | ||||
| 20 | Ticagrelor 替格瑞洛 |
In house | ● | ||||
| In house | The document has been approved | ||||||
| 21 | Glucosamine Sulfate Sodium Chloride 硫酸氨基葡萄糖氯化钠复盐 |
YBH | A | ||||
| YBH | APIs that have been approved for use in finished dosage in China |
